longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BofA Maintains Buy on British American Tobacco with Unchanged 5,300 GBp Price Target, Citing Resilient Fundamentals and Upcoming Growth Catalysts

Tip Ranks
Jul 15, 2026 at 01:26 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Bank of America analyst Bastien Agaud maintained a Buy rating on British American Tobacco with an unchanged price target of 5,300 GBp. The decision cites resilient fundamentals, supportive consumer data, and upcoming growth catalysts like product launches and the September Capital Markets Day. While H1 results may not be a major driver, management's prudent guidance and aligned forecasts support the recommendation.

Analyst Bastien Agaud of Bank of America Securities maintained a Buy rating on British American Tobacco, retaining the price target of p5,300.00.

TipRanks Welcomes a New ETF – NYSE:RANK

  • TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
  • RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Bastien Agaud has given his Buy rating due to a combination of factors including resilient fundamentals and supportive consumer data. He notes that British American Tobacco’s first-half results are unlikely to be a major catalyst, but that management’s tone and confidence on the earnings call, combined with guidance at the low end of its growth algorithm, suggest a degree of prudence rather than structural weakness.

He also highlights that BofA’s forecasts are broadly aligned with consensus on sales, EBIT and EPS, with some margin of safety embedded in EBIT expectations and a stable price target of 5,300 GBp. Regional dynamics show solid growth in the U.S. and manageable headwinds in other geographies, while upcoming product launches in Modern Oral and greater visibility expected at the September Capital Markets Day provide potential upside, justifying the maintained Buy recommendation.

According to TipRanks, Agaud is ranked #4083 out of 12329 analysts.

In another report released on July 13, Jefferies also maintained a Buy rating on the stock with a £55.00 price target.

Login to unlock1,051characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

British American Tobacco

British American Tobacco

USBTI

+0.69%

British American Tobacco p.l.c.

British American Tobacco p.l.c.

UKBATS

Bank of America

Bank of America

USBAC

LongbridgeAI